- Record: found
- Abstract: not found
- Conference Proceedings: not found
Abstract OT3-1-06: CIBOMA/2004-01_GEICAM/2003-11: A randomised phase III trial assessing adjuvant capecitabine (Cap) maintenance therapy after standard chemotherapy for triple-negative early breast cancer (EBC)
CE Barrios, A Lluch, M Ruiz-Borrego, J Bines, L Torrecillas, E. CARRASCO, JGM Segalla, A. RUIZ, JA Garcia-Saenz, R torres, J de la Haba-Rodriguez, E. GARCÍA-MARTÍNEZ, S Morales, H Gomez, J. Salvador-Bofill, A. HERNANDO, M. MARTÍN, J Bines, E. García-Martínez, H. GÓMEZ, A Hernando
2013
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Comments
Comment on this article
scite_
Similar content3,047
- First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-positive early breast cancer (EBC)Authors: MJ Piccart-Gebhart